Introduction
Synergohymenotropic toxins (SHT toxins) are bicomponent, non-associated exoproteins (class S and class F components) that are able to induce pores in membranes synergically [ 11. They promote the release of inflammatory mediators [ 11.
SHT toxins constitute a family of toxins including three kinds of loci. (1) y-Haemolysin and its variants from Staphylococcus aureus are made up of two class S (HlgA, HlgC) components and a class F (HlgB) component [2] . One of the genes (hZgA) is separately transcribed, the other two (hZgC and hZgB) are cotranscribed. The haemolysin is leukotoxic and haemolytic in vitro [3] . (2) The Panton-Valentine leukocidin (PVL) consists of only one class S (LukS-PVL) component and one class F (LukF-PVL) component [2] . It is highly leukotoxic and dermonecrotic for rabbit skin. The components HlgA and HlgC are structurally and functionally similar to LukS-PVL, whereas HlgB is structurally and functionally close to LukF-PVL [l, 4, 51 . Class S components have only 20-22% sequence similarity with S. aureus ahaemolysin, whereas class F components have 27-28% sequence similarity [4] . PVL and y-haemolysin genes are not equally distributed amongst S. aureus strains; y-haemolysin genes are constitutive of most S. aureus isolates (99% of clinical isolates) [6] but PVL genes are rarely encountered in randomly selected isolates [7, 81 . PVL-producing S. aureus strains are strongly associated with furunculosis. Leukotoxicity is not the sole characteristic of these toxins; their major virulence role would be the compromising of cellular immunity. At the molecular level, sublytic amounts of PVL have been shown to induce granule secretion [9, 101 from human polymorphonuclear leucocytes (PMNL) and the release of leukotriene B4 as well as interleukin (1L)-8 [ 1 I]. These mediators may be responsible for the toxin effects observed when the toxins are injected intradermally [7, 8, 111 . The role of y-haemolysin in inflammatory mediator release is still unknown.
Recently it has been reported that PVL-producing strains also have the genes encoding and producing yhaemolysin [ 121. Thus, six possible combinations of type S and type F proteins occur in such strains and potentially could lead to six toxins of different significance in bacterial pathogenesis. This study investigated the interaction of all the possible toxin combinations with human granulocytes -cells of the first defence ' line. Therefore, inflammatory mediators of the non-specific host defence which play an important role in host defence against invading microorganisms or toxins were analysed. The generation of oxygen metabolites (chemiluminescence response), enzyme activity (P-glucuronidase) and histamine release, as well as IL-8 generation, were studied.
Materials and methods

Toxin production
The three components of y-haemolysin (HlgA, HlgB, HlgC) and the two components of PVL (LukS-PVL, LukF-PVL) (Table 1) were simultaneously purified from culture supernates of S. aureus ATCC 49775 as described previously [3, 7, 111 . Purified proteins were tested by immunoprecipitation with affinity-purified antibodies against the toxin subunits. The precise characterisation of the purified fractions was performed by N-terminal sequencing. S and F components by themselves had no activity with regard to inflammatory mediator release or to cytokine release. Thus, they were not contaminated with LPS or superantigens.
Buffer
The buffer used for washing the cells and for assay of mediator release consisted of 137 mM NaC1, 8 mM Na2HP04, 3mM KCl and 3mM KH2PO4, pH 7.4 (modified Dulbecco's PBS).
Cell viability
Cell viability was determined by trypan blue exclusion.
Preparation of PMNLs and a human lymphocytemonocyte-basophil cell suspension (LMB)
PMNLs were isolated from 200 ml of heparinised blood (15 U/ml) from three healthy donors by separation on a Ficoll-metrizoate gradient followed by 
Studies on cellular activation
To study enzyme activity, histamine release and IL-8 generation, human PMNL (1 X lo7 cells/500 pl) or human LMB (5 X lo6 cells/500 pl) were stimulated in the presence of Ca2+/Mg2+ ( 0 . 6 / l m~) with 50 pl of buffer (control) or with 50 pl of the various toxin combinations (Table 1) for the indicated time periods at 37°C. The appropriate supernates of stimulated cells were analysed for enzymes, histamine or IL-8.
Histamine release from human basophilic granulocytes
The washed cells (5 X lo6 LMB/5OO pl) were stimulated in the presence of Ca2+ (1 mM) and Mg2+ (0.5 mM) with 50 pl of PBS (buffer control), with M L P M), with Luk-PVL (S, F, S + F components) or with y-haemolysin (S, F, S + F components) for 60 min at 37°C. Cells were centrifuged for 15 min at 300 g, deproteinised by the addition of HC104 (2'30, 2 ml) and subsequently analysed for histamine content by the flurophotometric analyser technique (Autoanalyser Technicon, Bad Vilbel, Germany) [ 1 11. Histamine dihydrochloride dissolved in HCLO4 2% served as a control. Cells in the presence of buffer and the bacterial supernate at the appropriate dilution served as negative controls. For the determination of the total cellular histamine content (1 00%) the cells were disrupted by the addition of 2 ml of HC104 [ l 11.
IL-8 assay
IL-8 release was determined by a sandwich ELISA according to Bazzoni et al. [14] . Each well of a 96-well plate (Nunc Maxisorb, Roskilde, Denmark) was precoated overnight at 4°C with 100 pl of PBS/Tween 20 (0.1 %) containing anti-IL-8 antibodies at a concentration of 5 pglml. The plates were washed three times with PBS/Tween, the appropriate samples or IL-8 standard (recombinant human IL-8; Calbiochem, Bad Soden, Germany) were added and incubation proceeded for 2 h at 37°C. Thereafter, alkaline phosphatase-linked anti-IL-8 antibody was added. After addition of pnitrophenylphosphate (1 5 mg/ml) for quantification, an ELISA reader and Mikrotek software (SLT Labinstruments, Crailsheim, Germany) were used to determine the amount of IL-8 released.
Determination of P-glucuronidase release
The release of P-glucuronidase was determined as described previously [ 111. Enzyme activities were calculated as the percentage of the total enzyme activities available after sonication of unstimulated PMNL (lo7 cells).
Chemiluminescence response of human gran ulocytes
Oxygen radical production was monitored by luminolenhanced chemiluminescence as described elsewhere [7] . PMNL (1 X lo6 cells/320 pl of PBS) were incubated in the presence of 0.6 mM calcium and 1 mM magnesium and 0.25 mM luminol for c. 15 min at 37°C until a stable signal was obtained. Subsequently, 50 pl of PBS (buffer control) or phorbol 12-myristate 13-acetate (PMA; M) or N-formyl-methionylleycyl-phenylalanine (fMLP) (1 0-4 M) or the appropriate samples were added. The production of oxygen radicals (chemiluminescence) was monitored in a Lumacounter M2080 (Lumac, Schaesberg, The Netherlands) over the indicated time periods.
PMNL were treated with PMA (1 O-' M) in the absence or presence of the various potential toxins at the indicated concentrations to study the modulation of PMA-induced chemiluminescence response. The production of oxygen radicals (chemiluminescence) was monitored in a Lumacounter M2080 over the indicated time periods.
Statistical analysis
All data were calculated as means and standard deviations (n = 3) from three different donors. The significance was evaluated by Student's t test for independent means.
Results
Cellular activation
Previously studies showed that the Panton-Valentineleukocidin (Luk-PVL) is a potent inducer for inflammatory mediator release from human granulocytes and monocytes [9-1 I]. The present study analysed whether Table 2 . Viability of toxin-treated PMNL the toxin concentrations, composed of the S and F component, are more, similar, or less active than Luk-PVL. Inflammatory mediator release was analysedpreformed as well as newly generated; these are important in non-specific host defence against invading micro-organisms or their toxins, or both. The experimental design was chosen from previous experiments [ 111. Human PMNL ( lo7 cells/500 pl) or a human LMB cell suspension (5 X lo6 LMB/5OO pl) were incubated in the presence of the various toxins (S + F components) at different concentrations (2000, 1000,500, 50,0.5,5 or 0 ng) for up to 60 min at 37°C as described in Materials and methods. Cells were stimulated with the individual toxin subunits (S, F) separately as controls. Cells were analysed for viability and for their ability to generate oxygen metabolites; the cell supernates were analysed for enzyme activities 0-glucuronidase) and for histamine release, as well as for IL-8 content.
Viability
Trypan blue staining was used as a measure of membrane and cellular integrity. The cytotoxic activities of the six possible combinations of type S and type F components revealed that all of them were able to promote lysis of human PMNL (Table 2 ) and human LMB (data not shown). When tested alone, none of the five protein components induced any appreciable toxicity with PMNL or LMB. Treatment of PMNL with toxin at a concentration of 2000 ng (each component) showed cytotoxic effects for PMNL as verified by an increase in trypan blue-positive cells from 5 SD 2% (unstimulated cells) up to 50-80% independent of the toxin used (Table 2) . However, the toxins HlgA/HlgB and HlgA/LukF-PVL did not induce an increase in trypan blue-positive cells at a concentration of 500ng (Table 2) . Similar results were obtained with the LMB cell suspension. Within the LMB cell suspension the basophilic granulocytes (the source for histamine) and monocytes (the source for IL-8) showed similar susceptibilities towards the toxins. Therefore, in further experiments the maximal toxin concentration used was 1000 ng (each component). At toxin concentrations of S 50 ng (each component) no toxin combination induced an increase in trypan bluepositive cells (data not shown). 
Chemiluminescence
All toxins led to an increase in the chemiluminescence (CL) response in a dose-dependent manner up to a concentration of 50ng of each component. Fig. 1 shows the results for toxin concentrations of 50 ng and 500 ng (each component). As is apparent from Fig. 1 , the various toxins differed markedly in the profile of induced CL response. In this regard, the comparative potency for the induction of a chemiluminescence response was as follows: LukS-PVL/LukF-PVL = HlgA/LukF-PVL HlgA/HlgB. At a concentration of 500 ng (each component) (Fig. lb) Fig. l c that toxins at a concentration of 50 ng did not modulate the PMA-induced CL response. However, at a toxin concentration of 500 ng, the PMA-induced CL response was modulated (Fig. Id) . As expected, the two toxins HlgA/HlgB and HlgA/LukF-PVL (which are weak inducers of chemiluminescence response), suppressed the PMA-induced CL response to a significantly lesser degree than the other toxins due to their enhanced cytotoxic activity on human PMNL. 
Histamine release
Histamine presents a preformed mediator with potent vasodilatory effects. Fig. 3 shows the results for toxin concentrations of 500, 50 and 5 ng of each component. As the toxins differed with regard to histamine release. Again, the comparative potency to induce histamine release was LukS-PVL/LukF-PVL = LukS-PVL/HglB PVL = HlgA/HlgB.
> HlgC/lukF-PVL = HlgC/HlgB > HlgA/LukF-
IL-8 generation
IL-8 represents one important chemotactic factor for PMNL. Therefore, the effects of various toxins on IL-8 release from human LMB were studied. The results are presented in Table 3 . It is evident that LukS-PVL/LukF-PVL and Luk-S-PVL/HlgB, already at low concentrations (0.5 ng of each component) were the most potent inducers of IL-8 release, again followed by the toxins HlgC/LukF-PVL and HlgC/HlgB. The toxins containing HlgA as S component were significantly less active.
Discussion
S. aureus produces numerous toxins for which a role in staphylococcal diseases are more or less precisely characterised [ 1, 8, 151 . Staphylococcal synergohymenotropic toxins are able to exert toxic and biological effects on the membranes of defence cells because of the synergy of two non-associated exoproteins of class S and class F [l, 161. Class S components were recognised as binding specifically membranes of target cells prior to the secondary interaction of class F components [ 171. Data from the present study indicate that class S and class F components are interchangeable and give toxins with genuine biological activity.
The Phanton-Valentine leukocidin (Luk-PVL) was reported to be strongly associated with some necrotising primary cutaneous infections such as furuncles and dermonecrosis [ I , 81. Previous The molecular mechanisms underlying the distinct interaction of the various S components with the target membrane has not been studied yet. The F components, LukF-PVL and HlgB, had similar activity. These results indicate that the potency of a toxin to induce inflammatory mediator release is predominantly determined by the S component. The S component is responsible for the initial step in toxin action, i.e., binding to membranes [ 16, 171. Therefore, toxins LukS-PVL/LukF-PVL and LukS-PVL/HlgB were the most potent inducers of inflammatory mediator release from human granulocytes, followed by HlgC/LukF-PVL and HlgC/HlgB. The toxins HlgA/LukF-PVL and HlgA/HlgB were less potent inducers of inflammatory mediator release than the other toxins. These results parallel in-vivo models with rabbit skin. In this regard, HlgA/LukF-PVL and HlgA/HlgB did not induce acute inflammatory lesions when these toxins were injected intradermally into rabbit skin.
In the present experiments, inflammatory mediator release was only apparent when human PMNL were treated with both components simultaneously or when they were treated in the following sequence: S component, washing the target cells, addition of the F component. The opposite sequence, i.e., F component, washing of the target cells, then addition of the S component, did not induce any biological activity (data not shown) [ 11, 16, 171 . The data clearly show that these components were non-cytotoxic when tested individually and failed to induce mediator release from human effector cells. These results are supported by results from in-vivo testing on rabbit skin. All five components had minimal effects when injected intradermally alone in rabbit skin. Only high amounts of protein (30 000 ng) induced transient inflammatory lesions (data not shown).
Although crucial in defence against infection, neutrophils and their toxic contents and products have been implicated in the pathogenesis of tissue injury in important inflammatory diseases [ 18, 191. In this regard the neutrophil generates toxic oxygen metabolites and contains powerful degradative granule enzymes and toxic cationic proteins. The chemotactic cytokine IL-8 was found to be highly correlated with neutrophil cellular infiltration and their activation [20, 21] . Histamine, released by mast cells or basophils, for example, has been implicated as a potentially important mediator of inflammatory disease. In addition to its vasodilatory action, histamine can also affect the release of soluble mediators from other cell types. It is concluded that the potency of the various toxin combinations to induce inflammatory mediator release may reflect their significance in disease. These findings might explain why staphylococcal infection may appear as local or generalised infection to a different degree.
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